Although mechanisms by which TRAIL inhibits inflammation in autoimmune diseases remain to be elucidated, most previous studies attributed the anti-inflammatory effects to the proapoptotic activity of TRAIL via triggering apoptosis in inflammatory cells (12, 22, 30, 31). The gene discussed is TNFSF10; the disease is autoimmune disease.